Rezolute prices approximately $100 million stock and pre-funded warrant offering
RZLT•Rezolute priced an offering expected to raise approximately $100 million in gross proceeds, including 22,040,976 shares at $3.87 each and warrants covering up to 3.8 million shares. Closing is expected on or about November 16, 2026.
1. Offering terms
Rezolute priced an underwritten offering of common stock and pre-funded warrants expected to raise approximately $100 million in gross proceeds. It includes 22,040,976 common shares priced at $3.87 each and pre-funded warrants covering up to 3,800,000 shares at $3.869 per warrant, with a $0.001 per-share exercise price.
2. Use of proceeds
Closing is expected on or about November 16, 2026, subject to customary conditions. Net proceeds will support ersodetug commercialization preparation, working capital and general corporate purposes.
